glp 1 cv benefit Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology Glucagon-like peptide 1 receptor agonists:

According to the Global Burden of Disease Study, both type 1 and type 2 diabetes mellitus substantially contribute to chronic kidney disease (CKD)-related disability-adjusted life-years (DALYs)

If I give them pills, theyre disappointed

How are these Injections Administered

6) Promotes Healthy Ageing - Adequate nutrition helps preserve muscle mass, bone health, and physical function as we grow older, contributing to better quality of life

But Eimer emphasized that the findings should not discourage appropriate use of GLP-1 drugs, which have become increasingly popular for treating diabetes, obesity, cardiovascular disease and sleep apnea